Benefits
Rapid correction of Vitamin K deficiency
Supports normal blood clotting function
Effective reversal of warfarin-induced anticoagulation
Essential for newborn prophylaxis
USP-compliant quality assurance
Usage Instructions
Administered intramuscularly, intravenously, or subcutaneously as directed by a healthcare professional
Dosage depends on indication, patient age, and severity of deficiency
IV administration should be given slowly to minimize adverse reactions
For professional medical use only
Mechanism of Action
Phytonadione (Vitamin K1) acts as a cofactor in the hepatic synthesis of vitamin K–dependent clotting factors (II, VII, IX, and X). It restores normal coagulation by enabling the activation of these clotting proteins.
Indications
Phytonadione Injectable Emulsion USP 10 mg/mL is indicated for:
Treatment and prevention of Vitamin K deficiency
Management of hypoprothrombinemia due to anticoagulant therapy (e.g., warfarin)
Reversal of anticoagulant-induced bleeding
Prevention and treatment of hemorrhagic disease of the newborn
Correction of clotting factor deficiencies related to malabsorption or liver disease
Side Effects
Possible side effects may include:
Injection site reactions
Flushing or sweating
Dizziness
Allergic reactions
Rare: Anaphylactoid reactions with rapid IV administration
Precautions
Administer under medical supervision
Avoid rapid intravenous injection
Monitor coagulation parameters (e.g., INR) when used to reverse anticoagulation
Use caution in patients with liver disease
Emergency support should be available in case of hypersensitivity reactions
Contraindications
Known hypersensitivity to phytonadione (Vitamin K1) or any component of the formulation
Severe allergic reaction to previous Vitamin K injections
Use with caution in patients with a history of hypersensitivity to emulsified preparations